Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

No phase data

Trial Status

Recruiting1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT05356520Not ApplicableRecruiting
Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction
Siewert Type II Adenocarcinoma of Esophagogastric Junction
PrincipalinvestigatorStart date: 2022-05-01

Research Network

Collaboration Network

6 collaborators·15 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Henan Provincial People's Hospital

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Sandro Mattioli - Alma M Studiorum-University, MD

Department of Medical and Surgical Sciences

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Andrey Ryabov, MD, PhD

P.Herzen Moscow Oncological Research Institute

Moderately Similar
5 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Jian-Kun Hu, M.D. Ph.D.

West China Hospital

Moderately Similar
4 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction

Worked with same sponsors:

Tang-Du Hospital
Similarity Score30%

wei wang, M.D.,Ph.D

Guangdong PHTCM

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Nuriddin Abdulkhakimov, PhD

P.Herzen Moscow Oncological Research Institute

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Melissa Lumish, MD

University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center

Moderately Similar
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Pavel Smirnov

P.Herzen Moscow Oncological Research Institute

Moderately Similar
3 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

Vladimir Khomyakov, MD, PhD

P.Herzen Moscow Oncological Research Institute

Moderately Similar
4 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Similarity Score30%

lei wang, MD,PH.D

General Hospital of Ningxia Medical University

Related
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction

Worked with same sponsors:

First Affiliated Hospital Xi'an Jiaotong UniversityGeneral Hospital of Ningxia Medical University+4 more
Collaborated on 1 trial
Similarity Score14%

xuejun sun, MD,PH.D

First Affiliated Hospital Xi'an Jiaotong University

Related
1 trials

Shared therapeutic areas:

Siewert Type II Adenocarcinoma of Esophagogastric Junction

Worked with same sponsors:

First Affiliated Hospital Xi'an Jiaotong UniversityGeneral Hospital of Ningxia Medical University+4 more
Collaborated on 1 trial
Similarity Score14%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT05356520Not ApplicablePrincipalInvestigator

Comparison of Different Operations for Siewert Type II Adenocarcinoma of Esophagogastric Junction

Siewert Type II Adenocarcinoma of Esophagogastric Junction
Recruiting

All 1 trials loaded